Morphometrical approach for predicting regional lymph node micrometastatic load in canine mast cell tumours: Preliminary results

Veterinary and Comparative Oncology

Volumn 6, Issue 3, 2008, Pages 162-170

  Marconato, Laura ^a   Marchetti, V ^b   Francione, D ^b   Masserdotti, C ^c   Gregori, R ^b   Leotta, R ^b   Abramo, F ^b  

^a Clinica Veterinaria L'Arca   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Laboratorio d'Analisi Veterinarie San Marco   (Italy)

Author keywords

Dog; Mast cell tumour; Micrometastases; Nuclear morphometry; Regional lymph node

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

ANIMAL; ANIMAL DISEASE; ARTICLE; CELL NUCLEUS; DOG; DOG DISEASE; LYMPHOMA; PATHOLOGY; PREDICTION AND FORECASTING; URTICARIA PIGMENTOSA;

ANIMALS; CELL NUCLEUS; DOG DISEASES; DOGS; LYMPHOMA; MASTOCYTOSIS, CUTANEOUS; PREDICTIVE VALUE OF TESTS;

EID: 63849234700     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2008.00157.x     Document Type: Article

References (33)

1. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. The Journal of Small Animal Practice 1973; 14: 27-41.
2. Patnaik AK, Ehler WJ and MacEwen EG. Canine cutaneous mast cell tumour: morphologic grading and survival time in 83 dogs. Veterinary Pathology 1984; 21: 469-474.
3. Thamm DH and Vail DM. Mast cell tumours. In: Small Animal Clinical Oncology, 3rd edn., SJ Withrow and EG MacEwen, eds., Philadelphia, WB Saunders, 2001: 261-282.
4. Owen LN. TNM Classification of Tumours in Domestic Animals, 1st edn., Geneva, World Health Organization, 1980: 14-15.
5. Murphy S, Sparkes AH, Blunden AS, Brearley MJ and Smith KC. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. The Veterinary Record 2006; 158: 287-291.
6. Thamm DH, Mauldin EA and Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor - 41 cases (1992-1997). Journal of Veterinary Internal Medicine 1999; 13: 491-497.
7. Langenbach A, McManus M, Hendrick MJ, Shofer FS and Sorenmo KU. Sensitivity and specificity of methods of assessing the regional lymph nodes for evidence of metastasis in dogs and cats with solid tumors. Journal of the American Veterinary Medical Association 1992; 200: 1648-1658.
8. Cahalane AK, Payne S, Barber L, Duda LE, Henry CJ, Mauldin GE, Frimberger AE, Cotter SM and Moore AS. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). Journal of the American Veterinary Medical Association 2004; 225: 401-408.
9. Thamm DH, Turek MM and Vail DM. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases. The Journal of Veterinary Medical Science 2006; 68: 581-587.
10. Starz H, Balda BR, Kramer KU, Buchels H and Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91: 2110-2121.
11. Ikeguchi M, Sakatani T, Endo K, Makino M and Kaibara N. Computerized nuclear morphometry is a useful technique for evaluating the high metastastic potential of colorectal adenocarcinoma. Cancer 1999; 86: 1944-1951.
12. Nakamura K, Morisaki T, Noshiro H, Torata N, Kinukawa N and Tanaka M. Morphometric analysis of regional lymph nodes with and without metastasis from early gastric carcinoma. Cancer 2000; 88: 2438-2442.
13. Sekine J, Uehara M, Hideshima K, Irie A and Inokuchi T. Predictability of lymph node metastases by preoperative nuclear morphometry in squamous cell carcinoma of the tongue. Cancer Detection and Prevention 2003; 27: 427-433.
14. Wolberg WH, Street WN and Mangasarian OL. Importance of nuclear morphology in breast cancer prognosis. Clinical Cancer Research 1999; 5: 3543-3548.
15. Strefezzi R de F, Xavier JG and Catao-Dias JL. Morphometry of canine cutaneous mast cell tumors. Veterinary Pathology 2003; 40: 268-275.
16. Maiolino P, Cataldi M, Paciello O, Restucci B and De Vico G. Nucleomorphometric analysis of canine cutaneous mast cell tumours. Journal of Comparative Pathology 2005; 133: 209-211.
17. Maiolino P, Restucci B, Papparella S and De Vico G. Nuclear morphometry in squamous cell carcinomas of canine skin. Journal of Comparative Pathology 2002; 127: 114-117.
18. Martano M, Damiano S, Restucci B, Paciello O, Russo V and Maiolino P. Nuclear morphometry in canine acanthomatous ameloblastomas and squamous cell carcinomas. European Journal of Histochemistry 2006; 50: 125-130.
19. Simeonov R, Simeonova G. Computerized morphometry of mean nuclear diameter and nuclear roundness in canine mammary gland tumors on cytologic smears. Veterinary Clinical Pathology 2006; 35: 88-90.
20. Ciurea D, Wilkins RJ, Shalev M, Liu Z, Barba J and Gil J. Use of computerized interactive morphometry in the diagnosis of mammary adenoma and adenocarcinoma in dogs. American Journal of Veterinary Research 1992; 53: 300-303.
21. Roels SL, Van Daele AJ, Van Marck EA and Ducatelle RV. DNA ploidy and nuclear morphometric variables for the evaluation of melanocytic tumors in dogs and cats. American Journal of Veterinary Research 2000; 61: 1074-1079.
22. De Vico G, Maiolino P, Cataldi M, Mazzullo G and Restucci B. Nuclear morphometry in relation to lymph node status in canine mammary carcinomas. Veterinary Research Communications 2007; 31: 1005-1011.
23. Scott MA and Stckham SL. Basophils and mast cells. In: Schalm's Veterinary Hematology, 5th edn., BF Feldman, JG Zinkl and NC Jain, eds., Philadelphia, Lippincott Williams & Wilkins, 2000: 313-315.
24. Raskin RE. Skin and subcutaneous tissues. In: Atlas of Canine and Feline Cytology, RE Raskin and DJ Meyer, eds., Philadelphia, WB Saunders, 2001: 83.
25. Ayl RD, Couto CG, Hammer AS, Weisbrode S, Ericson JG and Mathes L. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Veterinary Pathology 1992; 29: 386-390.
26. Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, Noyes RD, Viar V, Cerrito PB and McMasters KM.; Sunbelt Melanoma Trial Study Group. Complications associated with sentinel lymph node biopsy for melanoma. Annals of Surgical Oncology 2003; 10: 676-680.
27. Wasserberg N, Tulchinsky H, Schachter J, Feinmesser M and Gutman H. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free. European Journal of Surgical Oncology 2004; 30: 851-856.
28. Turrel JM, Kitchell BE, Miller LM and Theon A. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. Journal of the American Veterinary Medical Association 1988; 193: 936-940.
29. Kim R, Emi M, Tanabe K and Arihiro K. Immunobiology of the sentinel lymph node and its potential role for antitumour immunity. The Lancet Oncology 2006; 7: 1006-1016.
30. Raskin RE. Lymphoid system. In: Atlas of Canine and Feline Cytology, RE Raskin and DJ Meyer eds., Philadelphia, WB Saunders, 2001: 95-97.
31. Thamm DH and Vail DM. Mast cell tumors. In: Withrow & MacEwen's Small Animal Clinical Oncology, SJ Withrow and DM Vail eds., St Louis, Saunders Elsevier, 2007: 402-424.
32. Bookbinder PF, Butt MT and Harvey HJ. Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs. Journal of the American Veterinary Medical Association 1992; 200: 1648-1650.
33. Wydner KS, Godyn JJ, Lee ML and Sciorra LJ. A new approach to the computer-assisted quantitative analysis of nuclear shape. Modern Pathology 1991; 4: 154-160.